1. Home
  2. BNR vs INLX Comparison

BNR vs INLX Comparison

Compare BNR & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • INLX
  • Stock Information
  • Founded
  • BNR 2014
  • INLX 1996
  • Country
  • BNR China
  • INLX United States
  • Employees
  • BNR N/A
  • INLX N/A
  • Industry
  • BNR Medical Specialities
  • INLX EDP Services
  • Sector
  • BNR Health Care
  • INLX Technology
  • Exchange
  • BNR Nasdaq
  • INLX Nasdaq
  • Market Cap
  • BNR 38.3M
  • INLX 40.8M
  • IPO Year
  • BNR 2020
  • INLX N/A
  • Fundamental
  • Price
  • BNR $8.37
  • INLX $12.13
  • Analyst Decision
  • BNR
  • INLX
  • Analyst Count
  • BNR 0
  • INLX 0
  • Target Price
  • BNR N/A
  • INLX N/A
  • AVG Volume (30 Days)
  • BNR 38.7K
  • INLX 1.4K
  • Earning Date
  • BNR 09-08-2025
  • INLX 11-12-2025
  • Dividend Yield
  • BNR N/A
  • INLX N/A
  • EPS Growth
  • BNR N/A
  • INLX N/A
  • EPS
  • BNR N/A
  • INLX N/A
  • Revenue
  • BNR $74,862,782.00
  • INLX $17,127,854.00
  • Revenue This Year
  • BNR $136.32
  • INLX N/A
  • Revenue Next Year
  • BNR N/A
  • INLX $14.19
  • P/E Ratio
  • BNR N/A
  • INLX N/A
  • Revenue Growth
  • BNR 5.20
  • INLX N/A
  • 52 Week Low
  • BNR $2.18
  • INLX $8.74
  • 52 Week High
  • BNR $11.12
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • BNR 51.90
  • INLX 61.76
  • Support Level
  • BNR $8.02
  • INLX $12.25
  • Resistance Level
  • BNR $9.55
  • INLX $12.68
  • Average True Range (ATR)
  • BNR 0.67
  • INLX 0.19
  • MACD
  • BNR -0.15
  • INLX 0.18
  • Stochastic Oscillator
  • BNR 30.29
  • INLX 64.97

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: